Oral manifestations of HIV disease

Mount Sinai Journal of Medicine

Volumn 65, Issue 5-6, 1998, Pages 322-332

  Sirois, David A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

HIV; Oral disease; Oral manifestations

Indexed keywords

AMPHOTERICIN B; CHLORHEXIDINE; CLOTRIMAZOLE; DIIODOHYDROXYQUIN; FLUCONAZOLE; HYDROCORTISONE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN;

DENTIST; EARLY DIAGNOSIS; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MOUTH DISEASE; REVIEW;

BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MOUTH DISEASES; MOUTH NEOPLASMS; MYCOSES; VIRUS DISEASES;

EID: 0031756693     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22:289-291.
2. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992 Dec 18; 41(RR-17):1-19.
3. Begg MD, Lamster IB, Panageas KS, et al. A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 1997; 3:176-183.
4. Glick M. Evaluation of prognosis and survival of HIV infected patients. Oral Surg Oral Med Oral Pathol 1992; 74:386-392.
5. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994; 77:344-349.
6. Glick M, Lurie D, Salkin LM, Muzyka B. Necrotizing ulcerative periodontitis: A marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 1994; 65(5):393-397.
7. Begg MD, Panageas KS, Lamster IB. Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol 1996; 82:276-283.
8. Ramos-Gomez FJ, Maldonado YA, Greenspan JS, et al. Risk factors for HIV-related orofacial soft-tissue manifestations in children. Pediatr Dent 1996; 18(2):121-126.
9. Lamster IB, Phelan JA, Zambon JJ, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunological parameters to oral lesions. Oral Surg Oral Med Oral Pathol 1994; 78(2):163-174.
10. Shiboski CH, Cohen JB, Katz MH, et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquir Immune Defic Syndr 1994; 7(9):964-971.
11. Ficarra G, Rafanelli D, Piluso S, et al. Oral Lesions among HIV-infected hemophiliacs. A study of 54 patients. Haematologica 1994; 79(2):148-153.
12. Hilton JF, Greenspan JS, Greenspan D, et al. Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs. Am J Epidemiol 1997; 145(2):164-174.
13. Brawner DL, Cutler JE. Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 1989; 27:1335-1341.
14. Thomas I. Superficial and deep candidosis. Int J Dermatol 1993; 32:778-783.
15. Brawner DL Hovan AJ. Oral candidiasis in HIV-infected patients. Curr Top Med Mycol 1995; 6:113-125.
16. Korting HC, Ollert M, Georgii A, Froschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavity of patients infected with human immunodeficiency virus. J Clin Microbiol 1989; 26:2626-2631.
17. Tsang PC, Porter SR, Scully C, et al. Biotypes of oral Candida albicans isolates in human immunodeficiency virus-infected patients from diverse geographic locations. J Oral Pathol Med 1995; 24(1):32-36.
18. Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73:171-180.
19. Klein RS, Harris CA, Butkus Small C, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Eng J Med 1984; 311:354-358.
20. Mooney M, Thomas I, Sirois DA. Oral candidiasis. Int J Dermatol 1995; 34:759-765.
21. Giuliana G, Pizzo G, Milici ME, et al. In vitro antifungal properties of mouthrinses containing antimicrobial agents. J Periodontol 1997; 68:729-733.
22. Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlorhexidine and nystatin rinses in the prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1992; 73:682-689.
23. Eversole LR. Viral infections of the head and neck among HIV sero-positive patients. Oral Surg Oral Med Oral Pathol 1992; 73:155-163.
24. Cowan FM, Johnson AM, Ashley R, et al. Relationship between antibodies to herpes simplex virus and symptoms of HSV infection. J Infect Dis 1996; 174:470-475.
25. Oliver L, Wald A, Kim M, et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med 1995; 4:228-232.
26. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997 Oct 16; 337(16):1105-1111.
27. Annunziato PW, Gershon A. Herpes simplex virus infections. Pediatr Rev 1996 Dec;17(12):415-423.
28. Spruance SL, Crumpacker CS, Overall JC. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 1982; 146:85-90.
29. Spruance SL, Crumpacker CS, Schnipper LE. Early, patient-initiated treatment of herpes simplex labialis with topical 10% acyclovir. Antimicrob Agents Chemother 1984; 25:553-555.
30. Raborn GW, McGaw WT, Grace M, Houle L. Herpes labialis treatment with acyclovir 5% ointment. J Can Dent Assoc 1989; 55:135-137.
31. Fiddian AP, Ivanyi L. Topical acyclovir in the management of recurrent herpes labialis. Br J Dermatol 1983; 109:321-326.
32. Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis. JAMA 1997; 277:1374-1379.
33. Greenspan D, Greenspan JS, Conant M, et al. Oral "hairy" leukoplakia in male homosexuals: Evidence of association with pappilomavirus and a herpes-group virus. Lancet 1984; 2:831-834.
34. Syrjanen S, Laine P, Happonen RP, Niemela M. Oral hairy leukoplakia is not a specific sign of HIV infection but related to immunosuppression in general. J Oral Pathol Med 1989; 18:28-31.
35. Felix DH, Watret K, Wray D, Southam JC. Hairy leukoplakia in an HIV-negative, nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol 1992; 74:563-566.
36. Glick M, Pliskin ME. Regression of oral hairy leukoplakia after oral administration of acyclovir. Gen Dent 1990; 38:374-375.
37. Greenspan JS, Greenspan D. Oral hairy leukoplakia: Diagnosis and management. Oral Surg Oral Med Oral Pathol 1989; 67:396-403.
38. Lozada-Nur F. Podophyllum resin 25% for treatment of oral hairy leukoplakia: An old treatment for a new lesion. J Acquir Immune Defic Syndr 1991; 4:543-546.
39. Jones AC, Freedman PD, Phelan JA, et al. Cytomegalovirus infections of the oral cavity. A report of six cases and a review of the literature. Oral Surg Oral Med Oral Pathol 1993; 75:76-85.
40. Drew WL, Sweet ES, Miner RC, Mocarski ES. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: Documentation with Southern blot hybridization. J Infect Dis 1984; 150:952-953.
41. Moore LVH, Moore WEC, Riley C, et al. Periodontal microflora of HIV positive subjects with gingivitis or adult periodontitis. J Periodontol 1993; 64:48-56.
42. Zambon JJ, Reynolds HS, Genco RJ. Studies of the subgingival microflora in patients with acquired immunodeficiency syndrome. J Periodontol 1990; 61:699-704.
43. Cockerell CJ, Whitlow MA, Webster GF, Friedman-Klien AE. Epithelioid angiomatosis: A distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet 1987; 2:654-656.
44. Glick M, Cleveland D. Oral mucosal bacillary (epithelioid) angiomatosis in a patient with AIDS associated with rapid alveolar bone loss - Report of a case. J Oral Pathol Med 1993; 22:235-239.
45. Feigal DW, Katz MH, Greenspan D. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: Three San Francisco cohorts. AIDS 1991; 5:519-525.
46. Flaitz CM, Su IJ, Wang YW, et al. Kaposi's sarcoma-associated herpes virus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: A PCR and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Feb; 83(2):259-264.
47. Mocroft A, Phillips AN, Halai R, et al. Anti-herpes virus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996 Sep; 10(10):1101-1105.
48. Phelan JA, Eisig S, Freedman PD, et al. Major aphthous-like ulcers in patients with AIDS. Oral Surg Oral Med Oral Pathol 1991; 71:68-72.
49. Muzyka BC, Glick M. Major oral ulcerations in HIV disease. Oral Surg Oral Med Oral Pathol 1994; 77:116-120.
50. Schrot RJ, Adelman HM, Linden CN, Wallach PM. Cystic parotid gland enlargement in HIV disease. The diffuse infiltrative lymphocytosis syndrome. JAMA 1997 Jul 9; 278(2):166-167.
51. Seddon BM, Padley SP, Gazzard BG. Differential diagnosis of parotid masses in HIV positive men: Report of five cases and review. Int J STD AIDS 1996 May-Jun; 7(3):224-227.
52. Greenberg MS, Glick M, Nghiem L, et al. Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 Mar; 83(3):334-339.
53. Hewitt DJ, McDougald M, Portenoy RK, et al. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 1997; 70:117-123.
54. Breitbart W, McDougald M, Rosenfeld B, et al. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain 1996; 68:315-321.
55. Breitbart W. Pain in AIDS. In: Jensen TS, Turner JA, Weisenfeld-Hallin Z, editors. Proceedings of the 8th World Congress on Pain. Progress in pain research and management, Vol. 8. Seattle (WA): IASP Press; 1997. pp. 63-100.
56. Centers for Disease Control and Prevention. 1993 sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993 Sep 24; 42(RR-14):1-102.
57. Serrano M, Bellas C, Campo E, et al. Hodgkin's disease in patients with antibodies to human immunodeficiency virus. Cancer 1990; 65:2248-2254.
58. Glick M, Muzyka BC. Alternative therapies for major aphthous ulcers. J Am Dent Assoc 1992; 123(7):61-65.
59. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336(21):1487-1493.